JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Vivek Rao
Mehmet C. Oz
Katharine A. Catanese
Michael Argenziano
Yoshifumi Naka
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, V.
Right arrow Articles by Naka, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, V.
Right arrow Articles by Naka, Y.
Related Collections
Right arrow Mechanical Circulatory Assistance

J Thorac Cardiovasc Surg 2003;125:855-862
© 2003 The American Association for Thoracic Surgery


Cardiopulmonary Support and Physiology

Revised screening scale to predict survival after insertion of a left ventricular assist device

Vivek Rao, MD, PhD, Mehmet C. Oz, MD, Margaret A. Flannery, FNP, Katharine A. Catanese, RN, Michael Argenziano, MD, Yoshifumi Naka, MD, PhD

From the Division of Cardiothoracic Surgery, New York Presbyterian Hospital and Columbia University, New York, NY.

Received for publication Sept 24, 2001. Revisions requested Jan 3, 2002; revisions received July 15, 2002. Accepted for publication July 23, 2002. Address for reprints: Vivek Rao, MD, PhD, FRCS(C), Toronto General Hospital, 200 Elizabeth St, EN 14-222, Toronto, Ontario, M5G 2C4 Canada (E-mail: vivek.rao{at}uhn.on.ca).

Background: We previously calculated a risk factor summation score that successfully predicted survival after insertion of a left ventricular assist device. We sought to validate our previous score by using a single center's clinical experience and to determine emerging risk factors for mortality after device insertion.
Methods: The clinical records of 130 consecutive patients who received the HeartMate VE left ventricular assist device (Thoratec Corp, Pleasanton, Calif) at our institution between June 1996 and March 2001 as a bridge to transplantation were reviewed. Univariate and multivariable analyses were performed to determine the predictors of operative mortality after device insertion. Using the relative risks for each identified variable, we devised a new risk factor summation score. The new and old scores were then compared by using linear regression analyses to determine whether the revised score improved statistical accuracy.
Results: Overall operative mortality was 25% (n = 33). The old score successfully predicted operative mortality in the current patient population (operative mortality of 38% for score >5 vs 13% for score <=5). However, the revised score improved risk discrimination (operative mortality of 46% for a score >5 vs 12% for a score <= to 5). Statistical accuracy was comparable between scores, but the relationship between observed and predicted outcomes was improved with the revised score.
Conclusions: The changing demographic profile and management of patients presenting for mechanical circulatory support has led to a change in the predictors of mortality after device insertion. Periodic remodeling and recalibration of risk indices helps to accurately predict outcomes in high-risk patient groups and identifies emerging risk factors for mortality.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The American Association for Thoracic Surgery.